+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Biosimilars Market 2026-2030

  • PDF Icon

    Report

  • 301 Pages
  • April 2026
  • Region: Global
  • TechNavio
  • ID: 5395376
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global biosimilars market is forecasted to grow by USD 38.17 billion during 2025-2030, accelerating at a CAGR of 13.3% during the forecast period. The report on the global biosimilars market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing patent expirations and intensifying focus on cost-effectiveness, rising global incidence of chronic and autoimmune diseases, technological advancements in progress in biomanufacturing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The global biosimilars market is segmented as below:

By Product Type

  • Monoclonal antibodies
  • Insulin
  • Human growth hormone
  • Others

By Application

  • Oncology and hematology
  • Endocrinology
  • Immunology
  • Nephrology

By Manufacturing Type

  • In-house manufacturing
  • Contract manufacturing

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Asia
  • Rest of World (RoW)
  • Rest of World (RoW)
This study identifies the strategic shift towards interchangeability and pursuit of bio betters as one of the prime reasons driving the global biosimilars market growth during the next few years. Also, expansion into novel therapeutic areas and increased focus on emerging markets and embracing vertical integration and advanced manufacturing technologies will lead to sizable demand in the market.

The report on the global biosimilars market covers the following areas:

  • Global biosimilars market sizing
  • Global biosimilars market forecast
  • Global biosimilars market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biosimilars market vendors that include Abbott Laboratories, Biocon Ltd., Dr. Reddys Laboratories Ltd., Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Kashiv Biosciences LLC, Mabxience Holding S.L., NeuClone Pty Ltd., Organon and Co., Pfizer Inc., Reliance Life Sciences Pvt. Ltd., Samsung Bioepis Co. Ltd., Sandoz Group AG, STADA Arzneimittel AG, Teva Pharmaceutical Ltd., Viatris Inc., Zentiva Group, Zydus Lifesciences Ltd. Also, the global biosimilars market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Manufacturing Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
  • Chart on Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
  • Chart on Overview on factors of disruption
2.4 Impact of drivers and challenges
  • Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
  • Chart on Parent Market
  • Data Table on - Parent Market
3.2 Market characteristics
  • Chart on Market characteristics analysis
3.3 Value chain analysis
  • Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
  • Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
  • Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
  • Chart on Global - Market size and forecast 2025-2030 ($ million)
  • Data Table on Global - Market size and forecast 2025-2030 ($ million)
  • Chart on Global Market: Year-over-year growth 2025-2030 (%)
  • Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Biosimilars Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biosimilars Market 2020 - 2024 ($ million)
5.2 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.4 Manufacturing Type segment analysis 2020 - 2024
  • Historic Market Size - Manufacturing Type Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 AI Impact on Global Biosimilars Market
6.2 Impact of Geopolitical Conflict on Global Biosimilars Market
7 Five Forces Analysis
7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
  • Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Product Type
8.1 Market segments
  • Chart on Product Type - Market share 2025-2030 (%)
  • Data Table on Product Type - Market share 2025-2030 (%)
8.2 Comparison by Product Type
  • Chart on Comparison by Product Type
  • Data Table on Comparison by Product Type
8.3 Monoclonal antibodies - Market size and forecast 2025-2030
  • Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
  • Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
  • Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
  • Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
8.4 Insulin - Market size and forecast 2025-2030
  • Chart on Insulin - Market size and forecast 2025-2030 ($ million)
  • Data Table on Insulin - Market size and forecast 2025-2030 ($ million)
  • Chart on Insulin - Year-over-year growth 2025-2030 (%)
  • Data Table on Insulin - Year-over-year growth 2025-2030 (%)
8.5 Human growth hormone - Market size and forecast 2025-2030
  • Chart on Human growth hormone - Market size and forecast 2025-2030 ($ million)
  • Data Table on Human growth hormone - Market size and forecast 2025-2030 ($ million)
  • Chart on Human growth hormone - Year-over-year growth 2025-2030 (%)
  • Data Table on Human growth hormone - Year-over-year growth 2025-2030 (%)
8.6 Others - Market size and forecast 2025-2030
  • Chart on Others - Market size and forecast 2025-2030 ($ million)
  • Data Table on Others - Market size and forecast 2025-2030 ($ million)
  • Chart on Others - Year-over-year growth 2025-2030 (%)
  • Data Table on Others - Year-over-year growth 2025-2030 (%)
8.7 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)
  • Data Table on Market opportunity by Product Type ($ million)
9 Market Segmentation by Application
9.1 Market segments
  • Chart on Application - Market share 2025-2030 (%)
  • Data Table on Application - Market share 2025-2030 (%)
9.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
9.3 Oncology and hematology - Market size and forecast 2025-2030
  • Chart on Oncology and hematology - Market size and forecast 2025-2030 ($ million)
  • Data Table on Oncology and hematology - Market size and forecast 2025-2030 ($ million)
  • Chart on Oncology and hematology - Year-over-year growth 2025-2030 (%)
  • Data Table on Oncology and hematology - Year-over-year growth 2025-2030 (%)
9.4 Endocrinology - Market size and forecast 2025-2030
  • Chart on Endocrinology - Market size and forecast 2025-2030 ($ million)
  • Data Table on Endocrinology - Market size and forecast 2025-2030 ($ million)
  • Chart on Endocrinology - Year-over-year growth 2025-2030 (%)
  • Data Table on Endocrinology - Year-over-year growth 2025-2030 (%)
9.5 Immunology - Market size and forecast 2025-2030
  • Chart on Immunology - Market size and forecast 2025-2030 ($ million)
  • Data Table on Immunology - Market size and forecast 2025-2030 ($ million)
  • Chart on Immunology - Year-over-year growth 2025-2030 (%)
  • Data Table on Immunology - Year-over-year growth 2025-2030 (%)
9.6 Nephrology - Market size and forecast 2025-2030
  • Chart on Nephrology - Market size and forecast 2025-2030 ($ million)
  • Data Table on Nephrology - Market size and forecast 2025-2030 ($ million)
  • Chart on Nephrology - Year-over-year growth 2025-2030 (%)
  • Data Table on Nephrology - Year-over-year growth 2025-2030 (%)
9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Manufacturing Type
10.1 Market segments
  • Chart on Manufacturing Type - Market share 2025-2030 (%)
  • Data Table on Manufacturing Type - Market share 2025-2030 (%)
10.2 Comparison by Manufacturing Type
  • Chart on Comparison by Manufacturing Type
  • Data Table on Comparison by Manufacturing Type
10.3 In-house manufacturing - Market size and forecast 2025-2030
  • Chart on In-house manufacturing - Market size and forecast 2025-2030 ($ million)
  • Data Table on In-house manufacturing - Market size and forecast 2025-2030 ($ million)
  • Chart on In-house manufacturing - Year-over-year growth 2025-2030 (%)
  • Data Table on In-house manufacturing - Year-over-year growth 2025-2030 (%)
10.4 Contract manufacturing - Market size and forecast 2025-2030
  • Chart on Contract manufacturing - Market size and forecast 2025-2030 ($ million)
  • Data Table on Contract manufacturing - Market size and forecast 2025-2030 ($ million)
  • Chart on Contract manufacturing - Year-over-year growth 2025-2030 (%)
  • Data Table on Contract manufacturing - Year-over-year growth 2025-2030 (%)
10.5 Market opportunity by Manufacturing Type
  • Market opportunity by Manufacturing Type ($ million)
  • Data Table on Market opportunity by Manufacturing Type ($ million)
11 Customer Landscape
11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
  • Chart on Market share by geography 2025-2030 (%)
  • Data Table on Market share by geography 2025-2030 (%)
12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
12.3 North America - Market size and forecast 2025-2030
  • Chart on North America - Market size and forecast 2025-2030 ($ million)
  • Data Table on North America - Market size and forecast 2025-2030 ($ million)
  • Chart on North America - Year-over-year growth 2025-2030 (%)
  • Data Table on North America - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - North America
  • Data Table on Regional Comparison - North America
12.3.1 US - Market size and forecast 2025-2030
  • Chart on US - Market size and forecast 2025-2030 ($ million)
  • Data Table on US - Market size and forecast 2025-2030 ($ million)
  • Chart on US - Year-over-year growth 2025-2030 (%)
  • Data Table on US - Year-over-year growth 2025-2030 (%)
12.3.2 Canada - Market size and forecast 2025-2030
  • Chart on Canada - Market size and forecast 2025-2030 ($ million)
  • Data Table on Canada - Market size and forecast 2025-2030 ($ million)
  • Chart on Canada - Year-over-year growth 2025-2030 (%)
  • Data Table on Canada - Year-over-year growth 2025-2030 (%)
12.3.3 Mexico - Market size and forecast 2025-2030
  • Chart on Mexico - Market size and forecast 2025-2030 ($ million)
  • Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
  • Chart on Mexico - Year-over-year growth 2025-2030 (%)
  • Data Table on Mexico - Year-over-year growth 2025-2030 (%)
12.4 Europe - Market size and forecast 2025-2030
  • Chart on Europe - Market size and forecast 2025-2030 ($ million)
  • Data Table on Europe - Market size and forecast 2025-2030 ($ million)
  • Chart on Europe - Year-over-year growth 2025-2030 (%)
  • Data Table on Europe - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Europe
  • Data Table on Regional Comparison - Europe
12.4.1 Germany - Market size and forecast 2025-2030
  • Chart on Germany - Market size and forecast 2025-2030 ($ million)
  • Data Table on Germany - Market size and forecast 2025-2030 ($ million)
  • Chart on Germany - Year-over-year growth 2025-2030 (%)
  • Data Table on Germany - Year-over-year growth 2025-2030 (%)
12.4.2 UK - Market size and forecast 2025-2030
  • Chart on UK - Market size and forecast 2025-2030 ($ million)
  • Data Table on UK - Market size and forecast 2025-2030 ($ million)
  • Chart on UK - Year-over-year growth 2025-2030 (%)
  • Data Table on UK - Year-over-year growth 2025-2030 (%)
12.4.3 France - Market size and forecast 2025-2030
  • Chart on France - Market size and forecast 2025-2030 ($ million)
  • Data Table on France - Market size and forecast 2025-2030 ($ million)
  • Chart on France - Year-over-year growth 2025-2030 (%)
  • Data Table on France - Year-over-year growth 2025-2030 (%)
12.4.4 Italy - Market size and forecast 2025-2030
  • Chart on Italy - Market size and forecast 2025-2030 ($ million)
  • Data Table on Italy - Market size and forecast 2025-2030 ($ million)
  • Chart on Italy - Year-over-year growth 2025-2030 (%)
  • Data Table on Italy - Year-over-year growth 2025-2030 (%)
12.4.5 Spain - Market size and forecast 2025-2030
  • Chart on Spain - Market size and forecast 2025-2030 ($ million)
  • Data Table on Spain - Market size and forecast 2025-2030 ($ million)
  • Chart on Spain - Year-over-year growth 2025-2030 (%)
  • Data Table on Spain - Year-over-year growth 2025-2030 (%)
12.4.6 The Netherlands - Market size and forecast 2025-2030
  • Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
  • Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
  • Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
  • Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
12.5 Asia - Market size and forecast 2025-2030
  • Chart on Asia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Asia - Market size and forecast 2025-2030 ($ million)
  • Chart on Asia - Year-over-year growth 2025-2030 (%)
  • Data Table on Asia - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Asia
  • Data Table on Regional Comparison - Asia
12.5.1 China - Market size and forecast 2025-2030
  • Chart on China - Market size and forecast 2025-2030 ($ million)
  • Data Table on China - Market size and forecast 2025-2030 ($ million)
  • Chart on China - Year-over-year growth 2025-2030 (%)
  • Data Table on China - Year-over-year growth 2025-2030 (%)
12.5.2 India - Market size and forecast 2025-2030
  • Chart on India - Market size and forecast 2025-2030 ($ million)
  • Data Table on India - Market size and forecast 2025-2030 ($ million)
  • Chart on India - Year-over-year growth 2025-2030 (%)
  • Data Table on India - Year-over-year growth 2025-2030 (%)
12.5.3 Japan - Market size and forecast 2025-2030
  • Chart on Japan - Market size and forecast 2025-2030 ($ million)
  • Data Table on Japan - Market size and forecast 2025-2030 ($ million)
  • Chart on Japan - Year-over-year growth 2025-2030 (%)
  • Data Table on Japan - Year-over-year growth 2025-2030 (%)
12.5.4 South Korea - Market size and forecast 2025-2030
  • Chart on South Korea - Market size and forecast 2025-2030 ($ million)
  • Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
  • Chart on South Korea - Year-over-year growth 2025-2030 (%)
  • Data Table on South Korea - Year-over-year growth 2025-2030 (%)
12.5.5 Thailand - Market size and forecast 2025-2030
  • Chart on Thailand - Market size and forecast 2025-2030 ($ million)
  • Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
  • Chart on Thailand - Year-over-year growth 2025-2030 (%)
  • Data Table on Thailand - Year-over-year growth 2025-2030 (%)
12.5.6 Indonesia - Market size and forecast 2025-2030
  • Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
  • Chart on Indonesia - Year-over-year growth 2025-2030 (%)
  • Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Rest of World (ROW)
  • Data Table on Regional Comparison - Rest of World (ROW)
12.6.1 Brazil - Market size and forecast 2025-2030
  • Chart on Brazil - Market size and forecast 2025-2030 ($ million)
  • Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
  • Chart on Brazil - Year-over-year growth 2025-2030 (%)
  • Data Table on Brazil - Year-over-year growth 2025-2030 (%)
12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  • Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
  • Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
12.6.3 UAE - Market size and forecast 2025-2030
  • Chart on UAE - Market size and forecast 2025-2030 ($ million)
  • Data Table on UAE - Market size and forecast 2025-2030 ($ million)
  • Chart on UAE - Year-over-year growth 2025-2030 (%)
  • Data Table on UAE - Year-over-year growth 2025-2030 (%)
12.6.4 Turkey - Market size and forecast 2025-2030
  • Chart on Turkey - Market size and forecast 2025-2030 ($ million)
  • Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
  • Chart on Turkey - Year-over-year growth 2025-2030 (%)
  • Data Table on Turkey - Year-over-year growth 2025-2030 (%)
12.6.5 Argentina - Market size and forecast 2025-2030
  • Chart on Argentina - Market size and forecast 2025-2030 ($ million)
  • Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
  • Chart on Argentina - Year-over-year growth 2025-2030 (%)
  • Data Table on Argentina - Year-over-year growth 2025-2030 (%)
12.6.6 South Africa - Market size and forecast 2025-2030
  • Chart on South Africa - Market size and forecast 2025-2030 ($ million)
  • Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
  • Chart on South Africa - Year-over-year growth 2025-2030 (%)
  • Data Table on South Africa - Year-over-year growth 2025-2030 (%)
12.6.7 Colombia - Market size and forecast 2025-2030
  • Chart on Colombia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
  • Chart on Colombia - Year-over-year growth 2025-2030 (%)
  • Data Table on Colombia - Year-over-year growth 2025-2030 (%)
12.6.8 Israel - Market size and forecast 2025-2030
  • Chart on Israel - Market size and forecast 2025-2030 ($ million)
  • Data Table on Israel - Market size and forecast 2025-2030 ($ million)
  • Chart on Israel - Year-over-year growth 2025-2030 (%)
  • Data Table on Israel - Year-over-year growth 2025-2030 (%)
12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
  • Increasing patent expirations and intensifying focus on cost-effectiveness
  • Rising global incidence of chronic and autoimmune diseases
  • Technological advancements in progress in biomanufacturing
13.2 Market challenges
  • Navigating evolving and complex regulatory frameworks
  • Intensive patent litigation and strategic obstacles
  • Overcoming physician and patient reluctance
13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
  • Strategic shift towards interchangeability and pursuit of bio betters
  • Expansion into novel therapeutic areas and increased focus on emerging markets
  • Embracing vertical integration and advanced manufacturing technologies
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
  • Overview on factors of disruption
14.4 Industry risks
  • Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
  • Companies covered
15.2 Company ranking index
  • Company ranking index
15.3 Market positioning of companies
  • Matrix on companies position and classification
15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
15.5 Biocon Ltd.
  • Biocon Ltd. - Overview
  • Biocon Ltd. - Business segments
  • Biocon Ltd. - Key offerings
  • Biocon Ltd. - Segment focus
  • SWOT
15.6 Dr. Reddys Laboratories Ltd.
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key news
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • SWOT
15.7 Fresenius Kabi AG
  • Fresenius Kabi AG - Overview
  • Fresenius Kabi AG - Product / Service
  • Fresenius Kabi AG - Key offerings
  • SWOT
15.8 Intas Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd. - Overview
  • Intas Pharmaceuticals Ltd. - Product / Service
  • Intas Pharmaceuticals Ltd. - Key offerings
  • SWOT
15.9 NeuClone Pty Ltd.
  • NeuClone Pty Ltd. - Overview
  • NeuClone Pty Ltd. - Product / Service
  • NeuClone Pty Ltd. - Key offerings
  • SWOT
15.10 Organon and Co.
  • Organon and Co. - Overview
  • Organon and Co. - Product / Service
  • Organon and Co. - Key offerings
  • SWOT
15.11 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Segment focus
  • SWOT
15.12 Reliance Life Sciences Pvt. Ltd.
  • Reliance Life Sciences Pvt. Ltd. - Overview
  • Reliance Life Sciences Pvt. Ltd. - Product / Service
  • Reliance Life Sciences Pvt. Ltd. - Key offerings
  • SWOT
15.13 Sandoz Group AG
  • Sandoz Group AG - Overview
  • Sandoz Group AG - Business segments
  • Sandoz Group AG - Key news
  • Sandoz Group AG - Key offerings
  • Sandoz Group AG - Segment focus
  • SWOT
15.14 STADA Arzneimittel AG
  • STADA Arzneimittel AG - Overview
  • STADA Arzneimittel AG - Business segments
  • STADA Arzneimittel AG - Key offerings
  • STADA Arzneimittel AG - Segment focus
  • SWOT
15.15 Teva Pharmaceutical Ltd.
  • Teva Pharmaceutical Ltd. - Overview
  • Teva Pharmaceutical Ltd. - Business segments
  • Teva Pharmaceutical Ltd. - Key news
  • Teva Pharmaceutical Ltd. - Key offerings
  • Teva Pharmaceutical Ltd. - Segment focus
  • SWOT
15.16 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus
  • SWOT
15.17 Zentiva Group
  • Zentiva Group - Overview
  • Zentiva Group - Product / Service
  • Zentiva Group - Key offerings
  • SWOT
15.18 Zydus Lifesciences Ltd.
  • Zydus Lifesciences Ltd. - Overview
  • Zydus Lifesciences Ltd. - Business segments
  • Zydus Lifesciences Ltd. - Key news
  • Zydus Lifesciences Ltd. - Key offerings
  • Zydus Lifesciences Ltd. - Segment focus
  • SWOT
16 Appendix
16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
16.4 Research methodology
  • Research methodology
16.5 Data procurement
  • Information sources
16.6 Data validation
  • Data validation
16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
16.8 Data synthesis
  • Data synthesis
16.9 360 degree market analysis
  • 360 degree market analysis
16.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by Manufacturing Type
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Biosimilars Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Manufacturing Type Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Product Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Product Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Product Type
Exhibit 41: Data Table on Comparison by Product Type
Exhibit 42: Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Insulin - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Insulin - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Insulin - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Insulin - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Human growth hormone - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Human growth hormone - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Human growth hormone - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Human growth hormone - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 58: Market opportunity by Product Type ($ million)
Exhibit 59: Data Table on Market opportunity by Product Type ($ million)
Exhibit 60: Chart on Application - Market share 2025-2030 (%)
Exhibit 61: Data Table on Application - Market share 2025-2030 (%)
Exhibit 62: Chart on Comparison by Application
Exhibit 63: Data Table on Comparison by Application
Exhibit 64: Chart on Oncology and hematology - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Oncology and hematology - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Oncology and hematology - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Oncology and hematology - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Endocrinology - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Endocrinology - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Endocrinology - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Endocrinology - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Immunology - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Immunology - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Immunology - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Immunology - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Nephrology - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Nephrology - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Nephrology - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Nephrology - Year-over-year growth 2025-2030 (%)
Exhibit 80: Market opportunity by Application ($ million)
Exhibit 81: Data Table on Market opportunity by Application ($ million)
Exhibit 82: Chart on Manufacturing Type - Market share 2025-2030 (%)
Exhibit 83: Data Table on Manufacturing Type - Market share 2025-2030 (%)
Exhibit 84: Chart on Comparison by Manufacturing Type
Exhibit 85: Data Table on Comparison by Manufacturing Type
Exhibit 86: Chart on In-house manufacturing - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on In-house manufacturing - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on In-house manufacturing - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on In-house manufacturing - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Contract manufacturing - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Contract manufacturing - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Contract manufacturing - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Contract manufacturing - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by Manufacturing Type ($ million)
Exhibit 95: Data Table on Market opportunity by Manufacturing Type ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: Abbott Laboratories - Overview
Exhibit 227: Abbott Laboratories - Business segments
Exhibit 228: Abbott Laboratories - Key news
Exhibit 229: Abbott Laboratories - Key offerings
Exhibit 230: Abbott Laboratories - Segment focus
Exhibit 231: SWOT
Exhibit 232: Biocon Ltd. - Overview
Exhibit 233: Biocon Ltd. - Business segments
Exhibit 234: Biocon Ltd. - Key offerings
Exhibit 235: Biocon Ltd. - Segment focus
Exhibit 236: SWOT
Exhibit 237: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 238: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 239: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 240: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 241: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 242: SWOT
Exhibit 243: Fresenius Kabi AG - Overview
Exhibit 244: Fresenius Kabi AG - Product / Service
Exhibit 245: Fresenius Kabi AG - Key offerings
Exhibit 246: SWOT
Exhibit 247: Intas Pharmaceuticals Ltd. - Overview
Exhibit 248: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 249: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 250: SWOT
Exhibit 251: NeuClone Pty Ltd. - Overview
Exhibit 252: NeuClone Pty Ltd. - Product / Service
Exhibit 253: NeuClone Pty Ltd. - Key offerings
Exhibit 254: SWOT
Exhibit 255: Organon and Co. - Overview
Exhibit 256: Organon and Co. - Product / Service
Exhibit 257: Organon and Co. - Key offerings
Exhibit 258: SWOT
Exhibit 259: Pfizer Inc. - Overview
Exhibit 260: Pfizer Inc. - Business segments
Exhibit 261: Pfizer Inc. - Key news
Exhibit 262: Pfizer Inc. - Key offerings
Exhibit 263: Pfizer Inc. - Segment focus
Exhibit 264: SWOT
Exhibit 265: Reliance Life Sciences Pvt. Ltd. - Overview
Exhibit 266: Reliance Life Sciences Pvt. Ltd. - Product / Service
Exhibit 267: Reliance Life Sciences Pvt. Ltd. - Key offerings
Exhibit 268: SWOT
Exhibit 269: Sandoz Group AG - Overview
Exhibit 270: Sandoz Group AG - Business segments
Exhibit 271: Sandoz Group AG - Key news
Exhibit 272: Sandoz Group AG - Key offerings
Exhibit 273: Sandoz Group AG - Segment focus
Exhibit 274: SWOT
Exhibit 275: STADA Arzneimittel AG - Overview
Exhibit 276: STADA Arzneimittel AG - Business segments
Exhibit 277: STADA Arzneimittel AG - Key offerings
Exhibit 278: STADA Arzneimittel AG - Segment focus
Exhibit 279: SWOT
Exhibit 280: Teva Pharmaceutical Ltd. - Overview
Exhibit 281: Teva Pharmaceutical Ltd. - Business segments
Exhibit 282: Teva Pharmaceutical Ltd. - Key news
Exhibit 283: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 284: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 285: SWOT
Exhibit 286: Viatris Inc. - Overview
Exhibit 287: Viatris Inc. - Business segments
Exhibit 288: Viatris Inc. - Key news
Exhibit 289: Viatris Inc. - Key offerings
Exhibit 290: Viatris Inc. - Segment focus
Exhibit 291: SWOT
Exhibit 292: Zentiva Group - Overview
Exhibit 293: Zentiva Group - Product / Service
Exhibit 294: Zentiva Group - Key offerings
Exhibit 295: SWOT
Exhibit 296: Zydus Lifesciences Ltd. - Overview
Exhibit 297: Zydus Lifesciences Ltd. - Business segments
Exhibit 298: Zydus Lifesciences Ltd. - Key news
Exhibit 299: Zydus Lifesciences Ltd. - Key offerings
Exhibit 300: Zydus Lifesciences Ltd. - Segment focus
Exhibit 301: SWOT
Exhibit 302: Inclusions checklist
Exhibit 303: Exclusions checklist
Exhibit 304: Currency conversion rates for US$
Exhibit 305: Research methodology
Exhibit 306: Information sources
Exhibit 307: Data validation
Exhibit 308: Validation techniques employed for market sizing
Exhibit 309: Data synthesis
Exhibit 310: 360 degree market analysis
Exhibit 311: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global global biosimilars market: Abbott Laboratories, Biocon Ltd., Dr. Reddys Laboratories Ltd., Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Kashiv Biosciences LLC, Mabxience Holding S.L., NeuClone Pty Ltd., Organon and Co., Pfizer Inc., Reliance Life Sciences Pvt. Ltd., Samsung Bioepis Co. Ltd., Sandoz Group AG, STADA Arzneimittel AG, Teva Pharmaceutical Ltd., Viatris Inc., Zentiva Group, Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic shift towards interchangeability and pursuit of bio betters."

According to the report, one of the major drivers for this market is the increasing patent expirations and intensifying focus on cost-effectiveness.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Biocon Ltd.
  • Dr. Reddys Laboratories Ltd.
  • Fresenius Kabi AG
  • Intas Pharmaceuticals Ltd.
  • Kashiv Biosciences LLC
  • Mabxience Holding S.L.
  • NeuClone Pty Ltd.
  • Organon and Co.
  • Pfizer Inc.
  • Reliance Life Sciences Pvt. Ltd.
  • Samsung Bioepis Co. Ltd.
  • Sandoz Group AG
  • STADA Arzneimittel AG
  • Teva Pharmaceutical Ltd.
  • Viatris Inc.
  • Zentiva Group
  • Zydus Lifesciences Ltd.